Michael Kneba

Title: Michael Kneba: Innovator in Nucleic Acid Amplification Technologies

Introduction

Michael Kneba is a notable inventor based in Westensee, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification. With a total of 2 patents, his work has implications for early diagnosis and treatment of lymphoproliferative disorders.

Latest Patents

Kneba's latest patents focus on nucleic acid amplification primers for PCR-based clonality studies. These inventions are crucial for the early diagnosis of lymphoproliferative disorders. The patents provide a set of nucleic acid amplification primers that include a forward primer and a reverse primer, capable of amplifying various rearrangements. These rearrangements include VH-JH IGH, DH-JH IGH, VK-JK IGK, and several others. The primers are designed for use in PCR-based clonality studies and can aid in the detection of minimal residual disease (MRD). Additionally, a kit comprising at least one set of these primers is also included in his patents.

Career Highlights

Throughout his career, Michael Kneba has worked with various institutions, including Erasmus University Rotterdam. His expertise in molecular biology and PCR technology has positioned him as a key figure in his field. Kneba's contributions have been instrumental in advancing diagnostic techniques for lymphoproliferative disorders.

Collaborations

Kneba has collaborated with notable professionals such as Jacobus Johannes Maria Van Dongen and Anthonie Willem Langerak. These collaborations have further enriched his research and development efforts in nucleic acid amplification technologies.

Conclusion

Michael Kneba's innovative work in nucleic acid amplification has made a significant impact on the early diagnosis of lymphoproliferative disorders. His patents and collaborations highlight his dedication to advancing medical technology.